OS Therapies Incorporated (OSTX)
NYSE: OSTX · Pharmaceutical Preparations · Rockville, MD · filing with the SEC since 2019
Filings
185 filings since 2017 beside 62 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jul 24, 2026.
Filings a yearinsider forms included
1111205910460
2026 counts to Nov 13, 2026.
Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Oct 5, 2026.SEC letters: 34 in the last 36 months, the newest Aug 21, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2026.A late-filing notice, Form NT 10-Q, filed Aug 15, 2025.A late-filing notice, Form NT 10-Q, filed Nov 14, 2024.A late-filing notice, Form NT 10-Q, filed May 15, 2024.A late-filing notice, Form NT 10-K, filed May 15, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Oct 19, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Oct 15, 2026
Oct 5, 2026
8-K items 1.01, 5.02, 8.01, 9.01
Major agreement signed; Officer or director change; Other event · Current report
Sep 29, 2026
Sep 9, 2026
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
Aug 12, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Aug 6, 2026
Aug 6, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Jul 31, 2026
Jul 7, 2026
8-K/A item 9.01
Financial statements and exhibits · Current report, amended
Jun 30, 2026
Jul 2, 2026
8-K items 1.01, 2.03, 3.02, 5.02, 8.01, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration; Officer or director change; Other event · Current report
Jun 30, 2026
Apr 2, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Mar 31, 2026
Mar 6, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Mar 4, 2026
Jan 12, 2026
8-K items 1.01, 3.02, 8.01, 9.01
Major agreement signed; Shares sold without registration; Other event · Current report
Jan 10, 2026
Oct 21, 2025
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
40 of 185 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.